1 suspended. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Suspended 1 |
Follow Respiratory Hypersensitivity: new trials by email Literature Review of Respiratory Hypersensitivity trials Research Report on Respiratory Hypersensitivity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Busonid® (Budesonide 200 mcg and 400 mcg) to Treat Asthma Not Controlled or Partially Controlled Busonid (budesonide 200mcg and 400mcg) - Asthma | Phase 3 | Suspended | Ache Laboratorios Farmaceuticos S.A. | 80 | 2019-12-01 | 2019-07-08 |
Asthma (1)
Bronchial Diseases (1) · Hypersensitivity (1) · Hypersensitivity, Immediate (1) · Immune System Diseases (1) · Lung Diseases (1) · Lung Diseases, Obstructive (1) · Respiratory Tract Diseases (1)
Budesonide (1)
Ache Laboratorios Farmaceuticos S.A. (1)
Brazil (1)
Elie Fiss (1)